Track topics on Twitter Track topics that are important to you
INPULSIS®-ON study indicates safety and efficacy of Ofev® (nintedanib) are maintained over the long term and consistent with prior findings from INPULSIS® trials1 Results from INPULSIS®-ON, the open-label extension from the two INPULSIS® Phase III trials, published in Lancet Respiratory … Continue reading
Cet article New study results provide evidence that Ofev® (nintedanib) slows progression of IPF beyond four years with consistent safety est apparu en premier sur Biotech 365.NEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs. They're usually caused by viruses, but they can also ...